Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) - Total Liabilities

Latest as of March 2026: CN¥1.77 Billion CNY ≈ $259.42 Million USD

Based on the latest financial reports, Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has total liabilities worth CN¥1.77 Billion CNY (≈ $259.42 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Beijing Wantai Biological Pharmacy Enter to evaluate the company's liquid asset resilience ratio.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Competitors by Total Liabilities

The table below lists competitors of Beijing Wantai Biological Pharmacy Enterprise Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Huaan Securities Co Ltd
SHG:600909
China CN¥82.90 Billion
Coca-Cola FEMSA S.A.B. de C.V
MX:KOFUBL
Mexico MX$186.25 Billion
Samsung Securities
KO:016360
Korea ₩67.93 Trillion
Shenzhen New Industries Biomedical
SHE:300832
China CN¥831.98 Million
Northam Platinum Holdings Ltd
JSE:NPH
South Africa ZAC28.15 Billion
Casella Waste Systems Inc
NASDAQ:CWST
USA $1.70 Billion
Erasca Inc
NASDAQ:ERAS
USA $67.71 Million
Blue Owl Capital Corporation
NYSE:OBDC
USA $8.86 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Beijing Wantai Biological Pharmacy Enterprise Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Beijing Wantai Biological Pharmacy Enter asset portfolio.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.21 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.15 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.13 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2025)

The table below shows the annual total liabilities of Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥2.01 Billion
≈ $294.27 Million
-10.28%
2024-12-31 CN¥2.24 Billion
≈ $327.99 Million
-20.83%
2023-12-31 CN¥2.83 Billion
≈ $414.31 Million
-22.74%
2022-12-31 CN¥3.66 Billion
≈ $536.25 Million
+47.56%
2021-12-31 CN¥2.48 Billion
≈ $363.41 Million
+168.98%
2020-12-31 CN¥923.29 Million
≈ $135.11 Million
+58.05%
2019-12-31 CN¥584.19 Million
≈ $85.49 Million
+31.50%
2018-12-31 CN¥444.24 Million
≈ $65.01 Million
-41.30%
2017-12-31 CN¥756.80 Million
≈ $110.74 Million
+52.96%
2016-12-31 CN¥494.76 Million
≈ $72.40 Million
+30.57%
2015-12-31 CN¥378.93 Million
≈ $55.45 Million
+68.27%
2014-12-31 CN¥225.19 Million
≈ $32.95 Million
+0.12%
2013-12-31 CN¥224.92 Million
≈ $32.91 Million
--

About Beijing Wantai Biological Pharmacy Enterprise Co Ltd

SHG:603392 China Biotechnology
Market Cap
$5.64 Billion
CN¥38.51 Billion CNY
Market Cap Rank
#3321 Global
#456 in China
Share Price
CN¥30.46
Change (1 day)
-0.23%
52-Week Range
CN¥26.27 - CN¥62.34
All Time High
CN¥142.90
About

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, and sells biological diagnostic tests and vaccines in China and internationally. The company offers in vitro diagnostics and automated laboratory instruments, including Wan600, Wan BC2800, WanTLA immunoassay and biochemistry analyzers; chemiluminescence and biochemistry tests, including novel diagnostic tests fo… Read more